Northeast India’s Only English and Hindi Satellite News Channel

Three COVID-19 vaccines at clinical trial stage in India: ICMR

First Published: 15th September, 2020 20:54 IST

Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr

Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.

“Three vaccines are at the clinical trial stage in India. Zydus Cadila and Bharat Biotech have completed phase-I trials. Results are being analysed. They have started recruitment for the second phase,” Dr Bhargava said at a press conference here.

He was replying to a question on the status of COVID-19 vaccines in the country.

“Serum Institute of India (SII) has completed phase II-B3 trials. They took seven days break and will start phase-III trial (with 1,500 patients at 14 locations) after clearances,” he added.

The Drugs Controller General of India (DCGI) had asked SII to suspend any new recruitment in phase 2 and 3 clinical trials for the COVID-19 vaccine till further orders after reports from AstraZeneca that it had paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness.

AstraZeneca, which has partnered with Oxford University for development of the vaccine, has since resumed trials in UK.

There is yet no specific drug and vaccine available yet for coronavirus. Dr Bhargava had said that four factors would need to be considered once India has a safe and effective vaccine against coronavirus – priority and fair distribution of the vaccine, logistics and roll out in a cold chain, stockpiling and training of people who are to be given this vaccine.

He said India has been rolling out other vaccines for many years and has the requisite know-how.

Experts say a sustained behavioural change is required at least till there is a safe and effective vaccine. This includes wearing a mask, proper hand hygiene and physical distancing.

India’s COVID-19 case count crossed the 49-lakh mark on Tuesday. A total of 49,30,237 cases have been reported in the country including 9,90,061 active cases, 38,59,400 cured/discharged/migrated patients and 80,776 deaths. (ANI)

COMMENTS

Leave a Reply

Your email address will not be published. Required fields are marked *

WE RECOMMEND

Banner
7 Indian nationals injured in Magdeburg Christmas market attack

Of these,three have been discharged from the hospital, while the Indian Mission is closely monitoring the condition of the remaining victims.

22nd December 2024
Banner
Nagaland MP Accuses Rahul Gandhi of Standing Too Close to Her, Making Her Feel Uncomfortable

MP Phangnon Konyak has filed a complaint with Rajya Sabha Chairman against Congress leader Rahul Gandhi

19th December 2024
Banner
GRAP Stage IV reintroduced in NCR as AQI breaches 400 mark

This comes after the Air Quality Index in Delhi breached the 400 mark. AQI was recorded as 399 at 9 pm and 401 at 10 pm.

17th December 2024
Banner
India, Bangladesh to commemorate 1971 war ‘Vijay Diwas’ with annual exchange of veterans today

The event also gave an opportunity to the tribal community to showcase their talent.

16th December 2024
Banner
Would You Pay Rs 1 Lakh for Tea? Dubai’s Luxe ‘Gold Karak’ Has Everyone Talking. What Makes It So Special?

Served in a pure silver cup and topped with 24-carat edible gold leaf, it’s more than just a drink.

15th December 2024